Skip to content

Clinical trials

Chlamydia Infections trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chlamydia Infections Phase: Not applicable Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20051
20102
20112
20132
20152
20183
20193
20202
20221
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting4
Terminated3
Not yet recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention4
Northwestern University3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Johns Hopkins Bloomberg School of Public Health2
National Institute of Allergy and Infectious Diseases (NIAID)2
Washington University School of Medicine2
Albert Einstein College of Medicine1
Children's Hospital Medical Center, Cincinnati1
Columbia University1
George Washington University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chlamydia Infections31
Gonorrhea27
Sexually Transmitted Diseases13
Trichomonas Infections7
Syphilis5
Acquired Immunodeficiency Syndrome4
Emergencies4
Disease3
HIV Infections2
Opioid-Related Disorders2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.